Skip to content
Search news/తెలుగు
LatestAir ForceBankingBreaking newsBusinessDefenceEducationFeatured VideosTuesday, 10 November 2026
DCGI

Topic

DCGI

3 stories · updated on 28 Jan 2022

DCGI Grants Regular Market Approval To COVAXIN and Covishield, Vaccines Against Wuhan Virus

Corona Virus

DCGI Grants Regular Market Approval To COVAXIN and Covishield, Vaccines Against Wuhan Virus

Corona Virus

Corona Virus

DCGI Approves Emergency Use Of COVAXIN On Children Between 2 To 18 Years Old Age Group

Corona Virus

SII Seeks Approval To Manufacture Russia's Sputnik V Against COVID-19 Illness, Applies To DCGI

Corona Virus

DCGI Approves Emergency Use Of COVAXIN On Children Between 2 To 18 Years Old Age Group

Corona Virus

SII Seeks Approval To Manufacture Russia's Sputnik V Against COVID-19 Illness, Applies To DCGI